SCHEMBL238351

SCHEMBL238351

O=C(O)c1ccncc1Oc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 8/20 0.59
PTGS1 P23219 4/20 0.50
PTGS2 P35354 3/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPK1 P28482 1/20 0.50
HSD17B10 Q99714 1/20 0.50
KDM4D Q6B0I6 3/20 0.49
KDM4E B2RXH2 2/20 0.49
KDM6B O15054 2/20 0.49
KDM4A O75164 2/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
THRB P10828 1/20 0.49
KMT2A Q03164 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CTNNB1 P35222 1/20 0.46
TSHR P16473 1/20 0.46
TSPO P30536 3/20 0.45
ALB P02768 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL944347 0.87 CTNNB1 (0.65) KDM4CPTGS1PTGS2ALDH1A1MAPK1
SCHEMBL2657045 0.86 KDM4C (0.56) KDM4CPTGS1PTGS2ALDH1A1MAPK1
SCHEMBL22868033 0.85 PTGS1 (0.52) KDM4CPTGS1PTGS2ALDH1A1KDM4D
SCHEMBL21056897 0.85 CA12 (0.51) KDM4CALDH1A1MAPK1HSD17B10KDM4D
SCHEMBL23012320 0.84 TDP1 (0.55) KDM4CPTGS1PTGS2ALDH1A1MAPK1
SCHEMBL7632984 0.82 ALDH1A1 (0.71) KDM4CALDH1A1MAPK1HSD17B10KDM4E
SCHEMBL9165102 0.81 KDM4C (0.47) KDM4CALDH1A1KDM4DKDM4EKDM6B
SCHEMBL17820304 0.81 ALDH1A1 (0.47) KDM4CPTGS1PTGS2ALDH1A1MAPK1
SCHEMBL1798 0.77 CTNNB1 (0.71) PTGS1PTGS2ALDH1A1HSD17B10KDM4E
SCHEMBL742273 0.77 CTNNB1 (0.65) KDM4CPTGS1PTGS2ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780821-B2 Inhibitors of fibroblast activation protein Praxis Biotech LLC (US) 2023-10-10 US disclosed
US-11780821-B2 Inhibitors of fibroblast activation protein Praxis Biotech LLC (US) 2023-10-10 US disclosed
US-11780821-B2 Inhibitors of fibroblast activation protein Praxis Biotech LLC (US) 2023-10-10 US disclosed
CN-112105354-A Fibroblast activation protein inhibitor 普拉西斯生物技术有限责任公司 2020-12-18 CN disclosed
EP-3723753-A1 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN Praxis Biotech LLC (US) 2020-10-21 EP disclosed
US-20190185451-A1 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN Praxis Biotech LLC 2019-06-20 US disclosed
US-20190185451-A1 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN Praxis Biotech LLC 2019-06-20 US disclosed
WO-2019118932-A1 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN Praxis Biotech LLC (US) 2019-06-20 WO disclosed
US-20120004244-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors BIOLIPOX AB (SW) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190185451-A1 INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN FAP, FIBP, FRS2 KDM4C 3750/4885PTGS1 2441/4885PTGS2 2982/4885
US-20120004244-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors LTC4S, LTB4R2, LTB4R KDM4C 2054/4885PTGS1 22/4885PTGS2 50/4885
US-11780821-B2 Inhibitors of fibroblast activation protein FAP, FIBP, FRS2 KDM4C 3750/4885PTGS1 2441/4885PTGS2 2982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.